Katherine’s practice focuses on preparing and prosecuting U.S., foreign, and international patent applications primarily in the firm’s Life Science and Biotechnology practice group.
Katherine is an associate skilled in biotechnology and related fields. She has experience drafting and prosecuting patent applications, responding to office actions, ex parte appeals, and advising clients on patentability, freedom‑to‑operate, infringement/non-infringement, and validity matters. Katherine has worked closely with clinical‑stage pharmaceutical and life sciences companies to develop and protect strategic U.S. and global patent portfolios. She has prepared and prosecuted patent applications covering technologies including genome editing, gene and cell therapies, diagnostics, biologics, medical devices, and small‑molecule therapeutics, and supported clients in due diligence, patent litigation (including ANDA and BPCIA matters), and post‑grant proceedings before the USPTO.
Before law school, Katherine earned her Ph.D. in biology at the University of Denver where her doctoral research focused on activity-regulated microRNAs that had implications in neuron growth, synaptic plasticity, and learning and memory. She earned her J.D. from Washington University School of Law, where she served as editor-in-chief of the Washington University Journal of Law and Policy.
Katherine joined Klarquist as an associate in 2026.